{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:49:08Z","timestamp":1788965348234,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00059-024-05241-6","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T17:01:57Z","timestamp":1710176517000},"page":"185-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting","Die neue ESC-Leitlinie zum akuten Koronarsyndrom und ihre Auswirkungen auf die Chest Pain Unit und zentrale Notaufnahme"],"prefix":"10.1007","volume":"49","author":[{"given":"Martin","family":"M\u00f6ckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"issue":"38","key":"5241_CR1","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne\u00a0RA, Rossello\u00a0X, Coughlan\u00a0JJ et\u00a0al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart\u00a0J 44(38):3720\u20133826","journal-title":"Eur Heart J"},{"issue":"5","key":"5241_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1373\/clinchem.2004.046292","volume":"51","author":"FS Apple","year":"2005","unstructured":"Apple\u00a0FS, Wu\u00a0AH, Mair\u00a0J et\u00a0al (2005) Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51(5):810\u2013824","journal-title":"Clin Chem"},{"issue":"3","key":"5241_CR3","first-page":"203","volume":"59","author":"J Searle","year":"2011","unstructured":"Searle\u00a0J, Danne\u00a0O, M\u00fcller\u00a0C, Mockel\u00a0M (2011) Biomarkers in acute coronary syndrome and percutaneous coronary intervention. Minerva Cardioangiol 59(3):203\u2013223","journal-title":"Minerva Cardioangiol"},{"issue":"14","key":"5241_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet\u00a0JP, Thiele\u00a0H, Barbato\u00a0E et\u00a0al (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart\u00a0J 42(14):1289\u20131367","journal-title":"Eur Heart J"},{"issue":"9","key":"5241_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00392-021-01821-2","volume":"110","author":"E Giannitsis","year":"2021","unstructured":"Giannitsis\u00a0E, Blankenberg\u00a0S, Christenson\u00a0RH et\u00a0al (2021) Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome. Clin Res Cardiol 110(9):1353\u20131368","journal-title":"Clin Res Cardiol"},{"key":"5241_CR6","doi-asserted-by":"publisher","first-page":"e05","DOI":"10.15420\/icr.2020.18","volume":"16","author":"K Chung","year":"2021","unstructured":"Chung\u00a0K, Wilkinson\u00a0C, Veerasamy\u00a0M, Kunadian\u00a0V (2021) Frailty scores and their utility in older patients with cardiovascular disease. Interv Cardiol 16:e5","journal-title":"Interv Cardiol"},{"issue":"5","key":"5241_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood\u00a0K, Song\u00a0X, MacKnight\u00a0C et\u00a0al (2005) A\u00a0global clinical measure of fitness and frailty in elderly people. Cmaj 173(5):489\u2013495","journal-title":"Cmaj"},{"issue":"17","key":"5241_CR8","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1177\/2047487318799438","volume":"25","author":"N Ekerstad","year":"2018","unstructured":"Ekerstad\u00a0N, Pettersson\u00a0S, Alexander\u00a0K et\u00a0al (2018) Frailty as an instrument for evaluation of elderly patients with non-ST-segment elevation myocardial infarction: a\u00a0follow-up after more than 5\u00a0years. Eur J Prev Cardiol 25(17):1813\u20131821","journal-title":"Eur J Prev Cardiol"},{"key":"5241_CR9","first-page":"192","volume":"22","author":"N Yoshioka","year":"2019","unstructured":"Yoshioka\u00a0N, Takagi\u00a0K, Morita\u00a0Y et\u00a0al (2019) Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction. Int J Cardiol Heart Vasc 22:192\u2013198","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"14","key":"5241_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jacc.2021.07.055","volume":"78","author":"KK Lee","year":"2021","unstructured":"Lee\u00a0KK, Bularga\u00a0A, O\u2019Brien\u00a0R et\u00a0al (2021) Troponin-guided coronary computed tomographic angiography after exclusion of myocardial infarction. J\u00a0Am Coll Cardiol 78(14):1407\u20131417","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5241_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen\u00a0K, Alpert\u00a0JS, Jaffe\u00a0AS et\u00a0al (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart\u00a0J 40(3):237\u2013269","journal-title":"Eur Heart J"},{"key":"5241_CR12","doi-asserted-by":"crossref","unstructured":"Giannitsis E, Garfias-Veitl T, Slagman A et\u00a0al (2022) Biomarkers-in-cardiology 8 RE-VISITED-consistent safety of early discharge with a\u00a0dual marker strategy combining a\u00a0normal hs-cTnT with a\u00a0normal copeptin in low-to-intermediate risk patients with suspected acute coronary syndrome\u2014a secondary analysis of the randomized biomarkers-in-cardiology 8 trial. Cells 11(2)","DOI":"10.3390\/cells11020211"},{"key":"5241_CR13","doi-asserted-by":"publisher","first-page":"490947","DOI":"10.1155\/2015\/490947","volume":"2015","author":"T Lindner","year":"2015","unstructured":"Lindner\u00a0T, Slagman\u00a0A, Senkin\u00a0A et\u00a0al (2015) Medical history of elderly patients in the emergency setting: not an easy point-of-care diagnostic marker. Emerg Med Int 2015:490947","journal-title":"Emerg Med Int"},{"issue":"6","key":"5241_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","volume":"36","author":"M M\u00f6ckel","year":"2015","unstructured":"M\u00f6ckel\u00a0M, Searle\u00a0J, Hamm\u00a0C et\u00a0al (2015) Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a\u00a0randomized, controlled clinical process study. Eur Heart\u00a0J 36(6):369\u2013376","journal-title":"Eur Heart J"},{"issue":"6","key":"5241_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/1354750X.2018.1460763","volume":"23","author":"D Riedlinger","year":"2018","unstructured":"Riedlinger\u00a0D, M\u00f6ckel\u00a0M, M\u00fcller\u00a0C et\u00a0al (2018) High-sensitivity cardiac troponin T for diagnosis of NSTEMI in the elderly emergency department patient: a\u00a0clinical cohort study. Biomarkers 23(6):551\u2013557","journal-title":"Biomarkers"},{"issue":"5","key":"5241_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/2048872614554197","volume":"4","author":"J Searle","year":"2015","unstructured":"Searle\u00a0J, Slagman\u00a0A, Stockburger\u00a0M et\u00a0al (2015) Use of copeptin in emergency patients with cardiac chief complaints. Eur Heart J Acute Cardiovasc Care 4(5):393\u2013402","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"10","key":"5241_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1373\/clinchem.2015.240580","volume":"61","author":"A Slagman","year":"2015","unstructured":"Slagman\u00a0A, Searle\u00a0J, M\u00fcller\u00a0C, M\u00f6ckel\u00a0M (2015) Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction. Clin Chem 61(10):1273\u20131282","journal-title":"Clin Chem"},{"issue":"3","key":"5241_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.amjmed.2015.10.016","volume":"129","author":"M Vafaie","year":"2016","unstructured":"Vafaie\u00a0M, Slagman\u00a0A, M\u00f6ckel\u00a0M et\u00a0al (2016) Prognostic value of undetectable hs Troponin\u00a0T in suspected acute coronary syndrome. Am J Med 129(3):274\u2013282.e2","journal-title":"Am J Med"},{"issue":"11","key":"5241_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","volume":"371","author":"G Montalescot","year":"2014","unstructured":"Montalescot\u00a0G, van \u2019t Hof\u00a0AW, Lapostolle\u00a0F et\u00a0al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N\u00a0Engl J Med 371(11):1016\u20131027","journal-title":"N Engl J Med"},{"issue":"4","key":"5241_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/1354750X.2023.2212913","volume":"28","author":"M M\u00f6ckel","year":"2023","unstructured":"M\u00f6ckel\u00a0M (2023) Perspectives on cardiovascular biomarkers: one fits all biomarkers are out, personalization is in. Biomarkers 28(4):353","journal-title":"Biomarkers"},{"issue":"8","key":"5241_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/1354750X.2020.1841293","volume":"25","author":"M M\u00f6ckel","year":"2020","unstructured":"M\u00f6ckel\u00a0M (2020) One fits all hs troponin or more personalized dual markers strategies in the primary diagnostic assessment of patients with suspected acute coronary syndrome? Biomarkers 25(8):611\u2013612","journal-title":"Biomarkers"},{"issue":"1","key":"5241_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/MEJ.0000000000000895","volume":"29","author":"M M\u00f6ckel","year":"2022","unstructured":"M\u00f6ckel\u00a0M (2022) Actual guidelines on non-ST-elevation acute coronary syndrome: how do they help in the emergency department? Eur J Emerg Med 29(1):2\u20134","journal-title":"Eur J Emerg Med"},{"issue":"23","key":"5241_CR23","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1093\/eurheartj\/ehr360","volume":"32","author":"J D\u00f6rler","year":"2011","unstructured":"D\u00f6rler\u00a0J, Edlinger\u00a0M, Alber\u00a0HF et\u00a0al (2011) Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Eur Heart\u00a0J 32(23):2954\u20132961","journal-title":"Eur Heart J"},{"issue":"2","key":"5241_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40256-018-0305-0","volume":"19","author":"F Lapostolle","year":"2019","unstructured":"Lapostolle\u00a0F, Van\u2019t Hof\u00a0AW, Hamm\u00a0CW et\u00a0al (2019) Morphine and ticagrelor interaction in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: ATLANTIC-morphine. Am J Cardiovasc Drugs 19(2):173\u2013183","journal-title":"Am J Cardiovasc Drugs"},{"issue":"27","key":"5241_CR25","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1056\/NEJMoa2101909","volume":"385","author":"S Desch","year":"2021","unstructured":"Desch\u00a0S, Freund\u00a0A, Akin\u00a0I et\u00a0al (2021) Angiography after out-of-hospital cardiac arrest without ST-segment elevation. N\u00a0Engl J Med 385(27):2544\u20132553","journal-title":"N Engl J Med"},{"issue":"9","key":"5241_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamacardio.2023.2264","volume":"8","author":"S Desch","year":"2023","unstructured":"Desch\u00a0S, Freund\u00a0A, Akin\u00a0I et\u00a0al (2023) Coronary angiography after out-of-hospital cardiac arrest without ST-segment elevation: one-year outcomes of a\u00a0randomized clinical trial. JAMA Cardiol 8(9):827\u2013834","journal-title":"JAMA Cardiol"},{"issue":"15","key":"5241_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa1816897","volume":"380","author":"JS Lemkes","year":"2019","unstructured":"Lemkes\u00a0JS, Janssens\u00a0GN, van der Hoeven\u00a0NW et\u00a0al (2019) Coronary angiography after cardiac arrest without ST-segment elevation. N\u00a0Engl J Med 380(15):1397\u20131407","journal-title":"N Engl J Med"},{"issue":"12","key":"5241_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jamacardio.2020.3670","volume":"5","author":"JS Lemkes","year":"2020","unstructured":"Lemkes\u00a0JS, Janssens\u00a0GN, van der Hoeven\u00a0NW et\u00a0al (2020) Coronary angiography after cardiac arrest without ST segment elevation: one-year outcomes of the COACT randomized clinical trial. JAMA Cardiol 5(12):1358\u20131365","journal-title":"JAMA Cardiol"},{"issue":"10","key":"5241_CR29","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMoa2212528","volume":"388","author":"C Hassager","year":"2023","unstructured":"Hassager\u00a0C, Schmidt\u00a0H, M\u00f8ller\u00a0JE et\u00a0al (2023) Duration of device-based fever prevention after cardiac arrest. N\u00a0Engl J Med 388(10):888\u2013897","journal-title":"N Engl J Med"},{"issue":"23","key":"5241_CR30","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","volume":"41","author":"A Bharadwaj","year":"2020","unstructured":"Bharadwaj\u00a0A, Potts\u00a0J, Mohamed\u00a0MO et\u00a0al (2020) Acute myocardial infarction treatments and outcomes in 6.5\u00a0million patients with a\u00a0current or historical diagnosis of cancer in the USA. Eur Heart\u00a0J 41(23):2183\u20132193","journal-title":"Eur Heart J"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-024-05241-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T14:03:32Z","timestamp":1716991412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-024-05241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["5241"],"URL":"https:\/\/doi.org\/10.1007\/s00059-024-05241-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"13 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. M\u00f6ckel declares speakers honoraria and consulting fees from BRAHMS GmbH, Roche Diagnostics and AstraZeneca and research support from Roche Diagnostics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this review article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}